ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,437Medicare Part D Prescriptions Filled, Including Refills

Rank: 146 out of 2888

$1.18M Total Retail Price of All Prescriptions

Rank: 139 out of 2888

697 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
30% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

19% of this provider’s 697 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

3% of this provider’s 14,768 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$68 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
HYDROCODONE-ACETAMINOPHEN 648 424 S3 1 4
SIMVASTATIN 522 461 2 2
AMLODIPINE BESYLATE 505 429 3 5
LEVOTHYROXINE SODIUM 484 461 4 1
LISINOPRIL 459 413 5 3
METFORMIN HCL 443 349 6 8
FUROSEMIDE 423 366 7 6
PRAVASTATIN SODIUM 367 364 8 12
ATORVASTATIN CALCIUM 367 290 8 9
METOPROLOL TARTRATE 318 279 10 10
CARVEDILOL 301 259 11 21
METOPROLOL SUCCINATE 298 257 12 11
POTASSIUM CHLORIDE 271 235 13 14
ZOLPIDEM TARTRATE 267 230 14 17
OMEPRAZOLE 218 186 15 7
CRESTOR 215 192 16 20
WARFARIN SODIUM 205 176 17 22
GLIMEPIRIDE 188 163 18 36
GABAPENTIN 185 136 19 13
TRAMADOL HCL-ACETAMINOPHEN 173 171 20 95
LISINOPRIL-HYDROCHLOROTHIAZIDE 164 158 21 28
LOSARTAN POTASSIUM 162 152 22 18
CLOPIDOGREL 149 135 23 30
CLONIDINE HCL 147 129 24 39
TRAMADOL HCL 145 109 25 16
CITALOPRAM HBR 143 119 26 24
CYMBALTA 138 120 27 44
NAMENDA 135 135 28 34
NEXIUM 129 94 29 19
PLAVIX 129 116 29 40
HYDROCHLOROTHIAZIDE 125 125 31 15
ISOSORBIDE MONONITRATE ER 122 108 32 51
BENICAR HCT 119 109 33 181
RAMIPRIL 118 110 34 73
NIASPAN 116 101 35 127
BYSTOLIC 115 115 36 99
SYNTHROID 115 101 36 52
TAMSULOSIN HCL 115 79 36 29
LOSARTAN-HYDROCHLOROTHIAZIDE 111 110 39 46
CARISOPRODOL 107 80 R 40 82
ALLOPURINOL 102 101 41 37
SERTRALINE HCL 100 94 42 27
MIRTAZAPINE 99 80 43 54
DIGOXIN 98 97 44 55
PANTOPRAZOLE SODIUM 96 80 45 33
FAMOTIDINE 96 76 45 75
LEVOFLOXACIN 96 76 45 57
ZETIA 95 78 48 81
DONEPEZIL HCL 95 84 48 26
TRIAMTERENE-HCTZ 93 89 50 63
FENOFIBRATE 85 73 51 65
LANTUS 83 58 52 45
MELOXICAM 83 67 52 31
CELEBREX 83 81 52 89
ESCITALOPRAM OXALATE 78 63 55 62
ADVAIR DISKUS 77 72 56 60
LOVASTATIN 77 73 56 41
PROMETHAZINE HCL 75 25 R 58 96
ATENOLOL 74 62 59 25
NAPROXEN 74 62 59 80
DIOVAN 74 63 59 35
TRAZODONE HCL 73 44 62 43
LIPITOR 72 57 63 78
LYRICA 71 40 64 69
DIOVAN HCT 70 58 65 61
HYDRALAZINE HCL 70 69 65 59
NIFEDIPINE ER 66 33 67 76
TRILIPIX 66 54 67 160
ESTRADIOL 64 36 R 69 139
ACTOS 62 51 70 108
DILTIAZEM ER 62 62 70 182
FLUTICASONE PROPIONATE 61 61 72 32
DEXILANT 60 34 73 186
METOLAZONE 60 37 73 215
FINASTERIDE 59 59 75 102
DOXYCYCLINE HYCLATE 56 37 76 123
BENAZEPRIL HCL 56 56 76 77
TRICOR 56 56 76 91
AMITRIPTYLINE HCL 56 37 R 76 74
CEFDINIR 55 44 80 194
PREMARIN 55 50 R 80 129
RANITIDINE HCL 54 35 82 56
GLYBURIDE-METFORMIN HCL 54 54 R 82 64
FLUOXETINE HCL 54 54 82 83
CLOTRIMAZOLE-BETAMETHASONE 52 49 85 136
JANUVIA 50 50 86 48
SULFAMETHOXAZOLE-TRIMETHOPRIM 50 40 86 88
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 9, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.